A major new research project is aiming to develop a filtration system that can generate ‘universal plasma’.
NHS Blood and Transplant has received £1.13 million funding from National Institute of Health Research to develop a filtration system able to remove anti-A and anti-B antibodies from blood plasma.
This technique could speed up getting plasma to patients who desperately need it, reduce the risk of patients having a reaction to plasma, as well as simplifying the supply of plasma to hospitals and reducing wastage of valuable blood donations.
NHS Blood and Transplant is collaborating on the three-year project with Nonwovens Innovation and Research Institute (NIRI) and Macopharma.
Dr Gail Miflin, medical and research director at NHS Blood and Transplant, said: “Plasma transfusion is an essential treatment for patients with life-threatening bleeding. Universal plasma would make it easier to ensure we can provide this in a timely and efficient way.”
Source: NHS Blood and Transplant
Disclaimer: The news stories shared on this site are used as a way to inform our members and followers of updates and relevant information happening in Haematology. The BSH does not endorse the content of news items from external sources, and is not in a position to verify the findings, accuracy or the source of any studies mentioned. Any medical or drugs information is provided as an information resource only, and is not to be relied on for any diagnostic or treatment purposes.
News service provided by Englemed News http://www.englemed.co.uk/